NASDAQ · AFCG

Advanced Flower Capital Inc.

$2.57 -$0.07 (-2.65%) 1D Market open

Key Metrics

$60.22M
Market cap
P/E · TTM
$24.56M
Revenue · TTM
−$13.31M
Net income
EPS · TTM $-0.60
Dividend yield
Free cash flow
Beta · 1Y 1.34
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its May 28 high, the share price fell 31%.

    Peak close $3.75 on May 28; trough close $2.57 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -31%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 13
    The stock moved -9.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 13
  • May 7
    The stock moved +11.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$60.22M
Enterprise value
Shares outstanding22.8M
52-wk range$2.06 – $5.10
Avg volume · 20D177.6K
Net cash
Book value / share$8.40
ExchangeNASDAQ
About Advanced Flower Capital Inc.
IPO dateMar 19, 2021
Employees

Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.45
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -86.7%
Net -54.2%
FCF
ROE / ROIC -6.9% · -29.0%

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF −$23.53M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-0.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings